Searched for
SOFTOVAC LUPIN
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Most difficult: Staying invested in businesses while ignoring noise called Gulf war; 19 stocks from different sectors to ‘hold’Businesses that create long-term wealth are those where the demand runway is long, the competitive position is strong, and the management i...
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Indian or MNC pharma companies? There are reasons to look at both: 5 pharma stocks with upside potential of up to 38%Around two decades ago, as Indian pharma firms first began to move into the US market, they faced many challenges, the biggest of which was...
- Nothing wrong in being bullish, if you know why & what you are doing: 7 large-cap stocks with an upside potential of 2 to 20%In the short term, what Trump says, the numbers from China, and what the US Fed does will determine stock prices. But in the long term, the...
- Use this ratio both in bullish and volatile markets. 6 stocks that fit the bill with upside potential of up to 37%Looking only at the PE ratio creates more than one problem. For one, it creates an issue in terms of buying based on PE; secondly, just bec...
- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...
- A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 yearWhen Donald Trump is back in the saddle, one thing is certain: Tariff wars. Yes, China will be the biggest target. But for all those who th...
- Trump & Tariffs: Pharma sector might escape the inevitable tariff troubles. 6 pharma stocks, 5 with an upside potential of up to 38%Exactly eight years ago, in 2016, when a reality TV star became US president, the global markets went into sharp decline on the day of surp...
- In volatile times, defensive stocks or defensive businesses? The two are different. 7 stocks from second category with an upside potential of up to 32%Last Friday was probably the sixth time in 2024 that practically all sectoral indices were in the red. Needless to say, the market breadth ...
- The yen connection: 4 Indian pharma stocks which benefit from the strength of Japanese yen with an upside potential of up to 15%Every event in the currency market has a twin impact, while some lose but there are others which also gain. But given the mayhem on the str...
- These healthcare and pharma stocks may deliver more than 20% in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
- They just happen to be listed in India, what matters to them is global developments: 5 stocks from two sectors with upside scope of up to 29%In the last month of volatility, there are some sectors which have shown a streak of out performance. They haven't fallen as much as nifty ...
- Ready for another round of re-rating even in a volatile market? 5 Indian pharma stocks with upside potential of up to 41%In the last two years, every sector has come into focus at one point of time or the other. Some came into limelight due to the fact of real...
- Business and valuation tailwinds to help in outperformance? 5 Indian pharma stocks with upside potential of up to 32%Just before the whole market was consumed by the PSU rally, one sector that came into the limelight after many years of underperformance wa...
- Defensive bet with macro tailwinds? 5 Indian pharma stocks with upside potential of up to 20%On Tuesday, when the whole market was reeling under pressure, two stocks reacted to their numbers in a positive direction. Both of them wer...
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...
- Stocks in news: LIC, GMR Airports, Lupin, Brigade Enterprises, MarutiThe Department of Economic Affairs has decided to grant a one-time exemption to Life Insurance Corp to achieve 25% minimum public sharehold...
- Lupin forays into OTC segment;eyes Rs 300 crore turnover in 5 yearsSoftovac's shift to OTC was piloted in West Bengal during which the brand witnessed a growth in sales of over 25 per cent, and post the suc...
- Isabgol-based products to cost 20% moreProminent isabgol-based laxative brands like BG, Telephone, Nature Care, Fybogel, Softovac, Isogel, Naturolax and Sanjeevani Isabgol may se...
Load More
